| scholarly article | Q13442814 |
| P2093 | author name string | Martin MA | |
| Rabson AB | |||
| Englund G | |||
| Buckler-White AJ | |||
| Ross EK | |||
| P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
| Characterization of antigen receptor response elements within the interleukin-2 enhancer | Q24632042 | ||
| Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat | Q24645992 | ||
| Rapid and efficient site-specific mutagenesis without phenotypic selection | Q27860608 | ||
| Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS | Q28262859 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| An inducible transcription factor activates expression of human immunodeficiency virus in T cells | Q29618434 | ||
| The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter | Q29620405 | ||
| Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro | Q33584734 | ||
| Cooperative interactions between transcription factors Sp1 and OTF-1. | Q33641962 | ||
| Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene | Q33879942 | ||
| Genome organization and transactivation of the human immunodeficiency virus type 2. | Q34048704 | ||
| Identification of a putative regulator of early T cell activation genes | Q34171263 | ||
| Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat | Q34563887 | ||
| The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat | Q34564367 | ||
| Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. | Q34564460 | ||
| Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer | Q34626976 | ||
| kappa B elements strongly activate gene expression in non-lymphoid cells and function synergistically with NF1 elements | Q35951032 | ||
| Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes | Q36682395 | ||
| In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity | Q36825840 | ||
| Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication | Q36830870 | ||
| The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. | Q36831819 | ||
| trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: a quantitative analysis. | Q36832567 | ||
| Constitutive and inducible Saccharomyces cerevisiae promoters: evidence for two distinct molecular mechanisms | Q36899311 | ||
| Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus | Q37546388 | ||
| Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation | Q38345116 | ||
| A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator | Q40650101 | ||
| Functional heterogeneity of mammalian TATA-box sequences revealed by interaction with a cell-specific enhancer | Q41199282 | ||
| TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes | Q41238682 | ||
| The SV40 enhancer contains two distinct levels of organization | Q42117036 | ||
| Definition of multiple, functionally distinct TATA elements, one of which is a target in the hsp70 promoter for E1A regulation | Q42501525 | ||
| Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. | Q43858457 | ||
| HIV-1 tat trans-activation requires the loop sequence within tar. | Q44349676 | ||
| Applications of the polymerase chain reaction in retroviral-mediated gene transfer and the analysis of gene-marked human TIL cells | Q44942700 | ||
| Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements | Q45345558 | ||
| Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). | Q45838520 | ||
| Tat trans-activates the human immunodeficiency virus through a nascent RNA target | Q45847022 | ||
| Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat | Q46674379 | ||
| Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. | Q48365300 | ||
| Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR | Q68097623 | ||
| Cooperativity and hierarchical levels of functional organization in the SV40 enhancer | Q69836859 | ||
| The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level | Q70213932 | ||
| Oligonucleotide-Directed Mutagenesis: A Simple Method Using Two Oligonucleotide Primers and a Single-Stranded DNA Template | Q72405563 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 4350-4358 | |
| P577 | publication date | 1991-08-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types | |
| P478 | volume | 65 |
| Q34059393 | A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. |
| Q36643835 | A distinct African lentivirus from Sykes' monkeys. |
| Q37518835 | A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency |
| Q41889977 | A preclinical approach for gene therapy of beta-thalassemia. |
| Q40016514 | A proliferative p53-responsive element mediates tumor necrosis factor alpha induction of the human immunodeficiency virus type 1 long terminal repeat |
| Q33277177 | Adaptation of HIV-1 depends on the host-cell environment |
| Q36637774 | An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences |
| Q36666995 | An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation |
| Q90594756 | Barriers for HIV Cure: The Latent Reservoir |
| Q36556421 | CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. |
| Q36719187 | CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies |
| Q45735674 | Characterisation of the long terminal repeat regions of South African human immunodeficiency virus type 1 isolates |
| Q34057748 | Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. |
| Q33745081 | Coexpression of NF-kappa B/Rel and Sp1 transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T-cell syncytia |
| Q33877492 | Combinatorial latency reactivation for HIV-1 subtypes and variants |
| Q43564279 | Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses |
| Q33782366 | Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutant |
| Q33398516 | Control of stochastic gene expression by host factors at the HIV promoter |
| Q41047792 | Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells. |
| Q33887759 | Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking |
| Q27650549 | Crystal Structure of NFAT Bound to the HIV-1 LTR Tandem κB Enhancer Element |
| Q33784841 | Development of a self-inactivating lentivirus vector. |
| Q34671618 | Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment |
| Q24562924 | Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1 |
| Q40041542 | Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants |
| Q40037851 | Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages |
| Q30428712 | Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes |
| Q89935915 | Diverse effects of interferon alpha on the establishment and reversal of HIV latency |
| Q35853659 | Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. |
| Q38358545 | Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-kappaB and Sp1 binding elements |
| Q39549399 | Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site. |
| Q39590547 | Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. |
| Q33716931 | Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I. |
| Q36656211 | Genetic differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque |
| Q39549272 | Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains |
| Q33819189 | Genetic variation and HIV-associated neurologic disease. |
| Q35888785 | Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection. |
| Q37974218 | HIV latency |
| Q36330062 | Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication |
| Q39579927 | Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat. |
| Q39606712 | Human immunodeficiency virus type 1 replication in the absence of integrase-mediated dna recombination: definition of permissive and nonpermissive T-cell lines |
| Q37011027 | Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner |
| Q36640831 | Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms |
| Q35877551 | Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-1alpha region but lacking NF-kappaB binding sites |
| Q33902078 | Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1. |
| Q35872048 | In vivo transcriptional regulation of the human immunodeficiency virus in the central nervous system in transgenic mice |
| Q36654807 | Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function. |
| Q35877855 | Induction of AIDS by simian immunodeficiency virus lacking NF-kappaB and SP1 binding elements |
| Q24802730 | Inhibition of HIV-1 replication in primary human monocytes by the IkappaB-alphaS32/36A repressor of NF-kappaB |
| Q35837788 | Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection |
| Q35828854 | Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells |
| Q28344365 | Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors |
| Q34671609 | Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation. |
| Q35841911 | Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo |
| Q33815611 | Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse |
| Q35862437 | Moloney murine leukemia virus activates NF-kappa B |
| Q36492916 | Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance |
| Q35838477 | Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication |
| Q37237849 | NF-kappa B homodimer binding within the HIV-1 initiator region and interactions with TFII-I |
| Q33849726 | NF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages |
| Q33783417 | Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription |
| Q94452372 | Nucleic acid recognition and antiviral activity of 1,4-substituted terphenyl compounds mimicking all faces of the HIV-1 Rev protein positively-charged α-helix |
| Q33844046 | OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection |
| Q37010662 | PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages |
| Q39685491 | RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication |
| Q35942658 | Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors. |
| Q33587139 | Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage |
| Q34229621 | Regulation of Mycobacterium tuberculosis-dependent HIV-1 transcription reveals a new role for NFAT5 in the toll-like receptor pathway |
| Q34364116 | RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members |
| Q36644443 | Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat |
| Q24673913 | Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection |
| Q36642257 | Role of tumor necrosis factor alpha in activation and replication of the tat-defective human immunodeficiency virus type 1. |
| Q36633683 | Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription f |
| Q36637533 | Selective amplification of simian immunodeficiency virus genotypes after intrarectal inoculation of rhesus monkeys |
| Q35851228 | Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat. |
| Q39581570 | Sequences just upstream of the simian immunodeficiency virus core enhancer allow efficient replication in the absence of NF-kappaB and Sp1 binding elements |
| Q28285441 | Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors |
| Q27485930 | Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production |
| Q39872155 | Sp1 transcription factor is required for in vitro basal and Tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat |
| Q27657031 | Structural Basis of HIV-1 Activation by NF-κB—A Higher-Order Complex of p50:RelA Bound to the HIV-1 LTR |
| Q35882489 | Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase. |
| Q39596337 | Structure-based mutagenesis of the human immunodeficiency virus type 1 DNA attachment site: effects on integration and cDNA synthesis. |
| Q40062345 | TAR-independent replication of human immunodeficiency virus type 1 in glial cells |
| Q36646158 | The NF-kappa B binding site is necessary for efficient replication of simian immunodeficiency virus of macaques in primary macrophages but not in T cells in vitro |
| Q36645938 | The RRE of human immunodeficiency virus type 1 contributes to cell-type-specific viral tropism |
| Q37638962 | The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells |
| Q35774352 | The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-κB activation through TGF-β-activated kinase 1. |
| Q36906001 | The effects of cocaine on HIV transcription |
| Q40545978 | The human immunodeficiency virus type 1 promoter contains a CATA box instead of a TATA box for optimal transcription and replication. |
| Q35888601 | The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth |
| Q34544409 | The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit |
| Q34306883 | The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. |
| Q38306433 | The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication |
| Q40042122 | Transcription factor AP-2 regulates human immunodeficiency virus type 1 gene expression. |
| Q35890307 | Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. |
| Q24523709 | Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter |
| Q35835956 | Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. |
| Q34288376 | p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease |
Search more.